Delivery Order SPE2DB22D2206-SPE2DB25FGR90

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.98 firm fixed-price delivery order is for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product, with a completion date of January 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,472.10 firm fixed price delivery order is for the supply of hydromorphone 1 mg/ml carpujctml, a pain management medication. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,137.70, is for the supply of hydromorphone 1 mg/ml carpujctml. This contract does not have a set-aside designation, indicating it was competitively awarded. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,111.80, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product, to support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,815.73, is a Firm Fixed Price Delivery Order for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $4,499.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of hydromorphone 1 mg/ml cartridges, a pain management medication, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 29, 2024. The contract is not designated as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML. The contract is a Firm Fixed Price agreement with a ceiling value of $4,065.00 and an ultimate completion date of August 16, 2024. This award is not set aside for any particular business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.76 firm fixed price delivery order is for hydromorphone hydrochloride extended-release 8 mg tablets, with a completion date of February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,741.00 and is for the delivery of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product. This contract award is not designated with a set-aside, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Hydromorphone 1ML 10S, a pharmaceutical product. The $1,271.61 delivery order was issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGR90
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,447.00 delivery order (SPE2DB22D2206|SPE2DB25FGR90) is for the supply of Hydromorphone 1 mg/ml Carpujctml, a pain management pharmaceutical. The contract is a firm fixed-price delivery order with an ultimate completion date of April 24, 2025.

Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 (SPE2DX), which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard. The current delivery order is not designated as a set-aside contract.

Generated 7/23/25, 9:52 AM